Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3
Loading...
Files
Identifiers
Publication date
Authors
Locke, Jeffrey B.
Morales Kucharski, María Gracia
Hilgers, Mark
Kedar, G. C.
Rahawi, Shahad
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Resistance to linezolid (LZD) occurs through mutations in 23S rRNA and ribosomal proteins L3 and L4 or through methylation of 23S rRNA by Cfr. Here we report novel L3 mutations, ΔSer145/His146Tyr and ΔMet169-Gly174, co-occurring with <I>cfr</I> in LZD-resistant <I>Staphylococcus aureus</I> isolates recovered from a hospital outbreak in Madrid, Spain. LZD MIC values (16, 32, or 64 μg/ml) correlated with the presence and severity of the L3 mutation. All isolates had TR-700 (torezolid) MIC values of ≤2 μg/ml.
Description
UNESCO Subjects
Keywords
Bibliographic reference
Locke, J. B., Morales, G., Hilgers, M., Kedar, G. C., Rahawi, S., Picazo, J. J., ..., & Stein, J. L. (2010). Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3. Antimicrobial Agents and Chemotherapy, 54(12), 5352-5355.